Cargando…

Acetylation changes tau interactome to degrade tau in Alzheimer’s disease animal and organoid models

Alzheimer's disease (AD) is an age‐related neurodegenerative disease. The most common pathological hallmarks are amyloid plaques and neurofibrillary tangles in the brain. In the brains of patients with AD, pathological tau is abnormally accumulated causing neuronal loss, synaptic dysfunction, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Heesun, Kim, Haeng Jun, Yang, Jinhee, Chae, Sehyun, Lee, Wonik, Chung, Sunwoo, Kim, Jisoo, Choi, Hyunjung, Song, Hyeseung, Lee, Chang Kon, Jun, Jae Hyun, Lee, Yong Jae, Lee, Kyunghyeon, Kim, Semi, Sim, Hye‐ri, Choi, Young Il, Ryu, Keun Ho, Park, Jong‐Chan, Lee, Dongjoon, Han, Sun‐Ho, Hwang, Daehee, Kyung, Jangbeen, Mook‐Jung, Inhee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974726/ https://www.ncbi.nlm.nih.gov/pubmed/31763743 http://dx.doi.org/10.1111/acel.13081

Ejemplares similares

Increased acetylation of Peroxiredoxin1 by HDAC6 inhibition leads to recovery of Aβ-induced impaired axonal transport
por: Choi, Heesun, et al.
Publicado: (2017)

Annexin A1 restores Aβ(1‐42)‐induced blood–brain barrier disruption through the inhibition of RhoA‐ROCK signaling pathway
por: Park, Jong‐Chan, et al.
Publicado: (2016)

HDAC6 Inhibitor Blocks Amyloid Beta-Induced Impairment of Mitochondrial Transport in Hippocampal Neurons
por: Kim, Chaeyoung, et al.
Publicado: (2012)

HDAC6 Inhibitors Rescued the Defective Axonal Mitochondrial Movement in Motor Neurons Derived from the Induced Pluripotent Stem Cells of Peripheral Neuropathy Patients with HSPB1 Mutation
por: Kim, Ji-Yon, et al.
Publicado: (2016)

Visuospatial memory impairment as a potential neurocognitive marker to predict tau pathology in Alzheimer’s continuum
por: Seo, Eun Hyun, et al.
Publicado: (2021)

Brain somatic mutations observed in Alzheimer’s disease associated with aging and dysregulation of tau phosphorylation
por: Park, Jun Sung, et al.
Publicado: (2019)

CHIP-mediated hyperubiquitylation of tau promotes its self-assembly into the insoluble tau filaments
por: Kim, Ji Hyeon, et al.
Publicado: (2021)

Self‐Aggregating Tau Fragments Recapitulate Pathologic Phenotypes and Neurotoxicity of Alzheimer's Disease in Mice
por: Le, Ly Thi Huong Luu, et al.
Publicado: (2023)

Synapsin-1 and tau reciprocal O-GlcNAcylation and phosphorylation sites in mouse brain synaptosomes
por: Kang, Min Jueng, et al.
Publicado: (2013)

Levosimendan inhibits disulfide tau oligomerization and ameliorates tau pathology in Tau(P301L)-BiFC mice
por: Lim, Sungsu, et al.
Publicado: (2023)

Amyloid β‐induced elevation of O‐GlcNAcylated c‐Fos promotes neuronal cell death
por: Choi, Heesun, et al.
Publicado: (2018)

Facilitated Tau Degradation by USP14 Aptamers via Enhanced Proteasome Activity
por: Lee, Jung Hoon, et al.
Publicado: (2015)

Pan-HDAC Inhibitors Promote Tau Aggregation by Increasing the Level of Acetylated Tau
por: Jeong, Hyeanjeong, et al.
Publicado: (2019)

Identification of disulfide cross-linked tau dimer responsible for tau propagation
por: Kim, Dohee, et al.
Publicado: (2015)

A logical network-based drug-screening platform for Alzheimer’s disease representing pathological features of human brain organoids
por: Park, Jong-Chan, et al.
Publicado: (2021)

CSF total tau/α-synuclein ratio improved the diagnostic performance for Alzheimer’s disease as an indicator of tau phosphorylation
por: Shim, Kyu Hwan, et al.
Publicado: (2020)

Tau Positron Emission Tomography Imaging in Degenerative Parkinsonisms
por: Lyoo, Chul Hyoung, et al.
Publicado: (2018)

Degradation or aggregation: the ramifications of post-translational modifications on tau
por: Park, Seoyoung, et al.
Publicado: (2018)

Red Ginseng Inhibits Tau Aggregation and Promotes Tau Dissociation In Vitro
por: Shin, Soo Jung, et al.
Publicado: (2020)

Abnormalities of plasma cytokines and spleen in senile APP/PS1/Tau transgenic mouse model
por: Yang, Seung-Hoon, et al.
Publicado: (2015)

Predicting amyloid PET positivity using plasma p‐tau181 and other blood‐based biomarkers
por: Kwon, Hyuk Sung, et al.
Publicado: (2023)

Role of the Lipid Membrane and Membrane Proteins in Tau Pathology
por: Bok, Eugene, et al.
Publicado: (2021)

Enlarged perivascular spaces are associated with decreased brain tau deposition
por: Kang, Koung Mi, et al.
Publicado: (2022)

Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer’s disease
por: Cho, Hanna, et al.
Publicado: (2020)

Increased CSF tau level is correlated with decreased lamina cribrosa thickness
por: Lee, Eun Ji, et al.
Publicado: (2016)

Conformation-specific Antibodies Targeting Aggregated Forms of α-synuclein Block the Propagation of Synucleinopathy
por: Choi, Minsun, et al.
Publicado: (2022)

Nanobiosensors for Non-Amyloidbeta-Tau Biomarkers as Advanced Reporters of Alzheimer’s Disease
por: Phan, Le Minh Tu, et al.
Publicado: (2020)

A novel HDAC6 inhibitor, CKD-504, is effective in treating preclinical models of huntington’s disease
por: Li, Endan, et al.
Publicado: (2023)

Statins induce insulin-degrading enzyme secretion from astrocytes via an autophagy-based unconventional secretory pathway
por: Son, Sung Min, et al.
Publicado: (2015)

TMEM52B suppression promotes cancer cell survival and invasion through modulating E-cadherin stability and EGFR activity
por: Lee, Yunhee, et al.
Publicado: (2021)

Sequestration of sorcin by aberrant forms of tau results in the defective calcium homeostasis
por: Kim, Song-In, et al.
Publicado: (2016)

Bimolecular Fluorescence Complementation; Lighting-Up Tau-Tau Interaction in Living Cells
por: Tak, HyeJin, et al.
Publicado: (2013)

Decoding Tumor Phenotypes for ALK, ROS1, and RET Fusions in Lung Adenocarcinoma Using a Radiomics Approach
por: Yoon, Hyun Jung, et al.
Publicado: (2015)

Aberrant role of ALK in tau proteinopathy through autophagosomal dysregulation
por: Park, Jisu, et al.
Publicado: (2021)

Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer’s Diseases
por: Duka, Valeriy, et al.
Publicado: (2013)

Tau immunotherapy is associated with glial responses in FTLD-tau
por: Kim, Boram, et al.
Publicado: (2021)

Increasing Tau 4R Tau Levels Exacerbates Hippocampal Tau Hyperphosphorylation in the hTau Model of Tauopathy but Also Tau Dephosphorylation Following Acute Systemic Inflammation
por: Barron, Matthew R., et al.
Publicado: (2020)

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)
por: Gibbons, Garrett S., et al.
Publicado: (2019)

Artificial intelligence-estimated biological heart age using a 12-lead electrocardiogram predicts mortality and cardiovascular outcomes
por: Baek, Yong-Soo, et al.
Publicado: (2023)

Bovine Serum Albumin-Immobilized Black Phosphorus-Based γ-Fe(2)O(3) Nanocomposites: A Promising Biocompatible Nanoplatform
por: Naskar, Atanu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i0rl66ofljl70eeoknhftobfjh